Ensemble Discovery Raises $15 Million

Ensemble Discovery Corp., a Cambridge, Mass.-based developer of a DNA-programmed chemistry platform for developing therapeutics and bioassays, has raised $15 million in Series B funding. The deal was tranched-out with the first $10 million coming in January, and the remainder being called down a few months later.


Backers included CMEA Ventures, ARCH Venture Partners, Flagship Ventures, Oxford Bioscience Partners, Harris & Harris Group, Aeneas Venture Corp. (Harvard University) and Boston University Technology Development Fund. www.ensemblediscovery.com